COMMUNIQUÉS West-GlobeNewswire

Olainfarm increases profitability and earns 7.5 million euros in nine months

30/11/2018 - 16:23

Unaudited consolidated Income Statement of JSC Olainfarm for nine months of 2018 shows that the sales of the Group have reached 89.5 million euros, which is a slight decrease by 1% compared to the same period of 2017. [...]

JSC Olainfarm Strengthens the Boards of Several Daughter Companies

30/11/2018 - 15:39

Board of JSC Olainfarm has decided to make some changes to Management Boards of Silvanols LLC, Latvijas Aptieka LLC and Tonus Elast LLC. Larisa Podlesnaja has left the Management Board of Tonus Elast to continue in [...]

Coherus BioSciences Announces Apexus Contract Agreement for 340B Hospitals and Clinics, and Q-Code Issuance from CMS

30/11/2018 - 15:30

REDWOOD CITY, Calif., Nov. 30, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS), today announced that the company has executed a 340B prime vendor program contract agreement with Apexus, LLC. Apexus is [...]

HEXO scoops two prizes at 2018 Canadian Cannabis Awards

30/11/2018 - 15:29

GATINEAU, Quebec, Nov. 30, 2018 (GLOBE NEWSWIRE) -- HEXO Corp (“HEXO” or the “Company”) (TSX:HEXO) was honoured for product innovation with two prestigious Canadian Cannabis Awards at the 2018 gala. Hydropothecary by [...]

HEXO remporte deux prix aux Canadian Cannabis Awards 2018

30/11/2018 - 15:29

GATINEAU, Québec, 30 nov. 2018 (GLOBE NEWSWIRE) -- HEXO Corp. (« HEXO » ou la « Société ») (TSX:HEXO ) a été honoré pour l'innovation de ses produits avec deux prestigieux prix canadiens du cannabis lors du gala de 2018 [...]

Clementia Announces the Departure of Chief Commercial Officer

30/11/2018 - 15:00

MONTREAL, Nov. 30, 2018 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc. (Nasdaq: CMTA), a clinical-stage biopharmaceutical company innovating treatments for people with ultra-rare bone disorders and other diseases, [...]

Clementia annonce le départ de son chef de la direction commerciale

30/11/2018 - 15:00

MONTRÉAL, 30 nov. 2018 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc. (Nasdaq : CMTA), une société biopharmaceutique au stade clinique proposant des traitements novateurs pour les personnes atteintes de troubles [...]

WW to Present at Nasdaq 39th Investor Conference

30/11/2018 - 15:00

NEW YORK, Nov. 30, 2018 (GLOBE NEWSWIRE) -- Weight Watchers International, Inc. (Nasdaq: WTW) (“WW”), a global wellness company and the world’s leading commercial weight management program, today announced that Nick [...]

Xenon Pharmaceuticals to Host Conference Call and Webcast to Provide Corporate Update and Overview of Presentations at the 2018 American Epilepsy Society (AES) Meeting

30/11/2018 - 15:00

BURNABY, British Columbia, Nov. 30, 2018 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical-stage biopharmaceutical company, today announced that it will host a conference call and live audio [...]

Radius Health Provides Updates on its Oncology Programs and Announces Scientific Presentations at 2018 San Antonio Breast Cancer Symposium (SABCS)

30/11/2018 - 15:00

Phase 3 elacestrant study has opened for enrollment Fast Track designation from the FDA for the Phase 3 study population Elacestrant pre-clinical data demonstrates further evidence of anti-tumor activity in breast [...]

Glass Lewis Recommends that Keryx Biopharmaceuticals Stockholders Vote “FOR” the Proposed Merger with Akebia Therapeutics

30/11/2018 - 14:55

BOSTON, Nov. 30, 2018 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX), a biopharmaceutical company focused on bringing innovative medicines to people with kidney disease, today announced that leading [...]

Agility Health Reports Third Quarter 2018 Financial Results

30/11/2018 - 14:40

HAMILTON, Ontario, Nov. 30, 2018 (GLOBE NEWSWIRE) -- Agility Health, Inc. (TSXV: AHI) (“ Agility Health ” or “ Corporation ”), a leading provider of orthotics, prosthetics and foot care services, today reported its [...]

Holding(s) in Company

30/11/2018 - 14:30

TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the [...]

Vilacto Bio Secured Patent Applications for LACTOACTIVE®

30/11/2018 - 14:30

NEW YORK, Nov. 30, 2018 (GLOBE NEWSWIRE) -- New York-based Vilacto Bio Inc. (OTC QB:VIBI) has secured the patent applications for LACTOACTIVE® covering rights in the US, Canada Europe and Hong Kong. The transaction was [...]

Assure Holdings Announces Results of Annual General Meeting of Shareholders

30/11/2018 - 14:30

DENVER, Nov. 30, 2018 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (TSXV: IOM; OTCPK: ARHH), a provider of intraoperative neuromonitoring services, is pleased to announce that it held its [...]

Wildflower Posts 9th Consecutive Quarter With Increased Revenue

30/11/2018 - 14:30

VANCOUVER, British Columbia, Nov. 30, 2018 (GLOBE NEWSWIRE) -- Wildflower Brands Inc. (CSE: SUN , OTC: WLDFF ) (the “ Company ”) announces more than $1M in sales in its first quarter, compared to $103,893 in the first [...]

SELLAS to Present Further Correlative Data from Phase 2b Trial of NeuVax + Herceptin® at the 2018 San Antonio Breast Cancer Symposium

30/11/2018 - 14:30

NEW YORK, Nov. 30, 2018 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (Nasdaq: SLS) (“SELLAS” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of novel cancer [...]

Oncology Venture A/S: Publication of financial report Q3 2018

30/11/2018 - 14:19

Press release Oncology Venture A/S: Publication of financial report for January – September 2018 Hørsholm, Denmark and Cambridge, MA, US, November 30 th , 2018 – Oncology Venture A/S (“Oncology Venture”) hereby [...]

Cocrystal Pharma Announces Presentation at the RespiDART 2018: Frontiers in Drug Development Against Respiratory Viruses Conference

30/11/2018 - 14:00

- Proprietary technology has the ability to fuel Cocrystal’s pipeline by effectively creating small molecule antiviral therapeutics that are safe, effective, convenient to administer and have the potential to address [...]